70 related articles for article (PubMed ID: 25667935)
21. CTLA4 gene polymorphisms influence the incidence of infection after renal transplantation in Chinese recipients.
Guo Y; Guo F; Wei C; Qiu J; Liu Y; Fang Y; Gao J
PLoS One; 2013; 8(8):e70824. PubMed ID: 24015180
[TBL] [Abstract][Full Text] [Related]
22. Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.
Guo Y; Gao J; Gao S; Shang M; Guo F
Oncotarget; 2016 Apr; 7(17):23088-95. PubMed ID: 27081086
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation.
Misra MK; Pandey SK; Kapoor R; Sharma RK; Agrawal S
Pharmacogenet Genomics; 2015 Jan; 25(1):19-29. PubMed ID: 25356901
[TBL] [Abstract][Full Text] [Related]
24. Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: data from a multicenter study.
Li Q; Wang B; Pan F; Zhang R; Xiao L; Guo H; Ma S; Zhou C
J Gastroenterol Hepatol; 2013 Aug; 28(8):1397-402. PubMed ID: 23432218
[TBL] [Abstract][Full Text] [Related]
25. Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk.
Wang L; Su G; Zhao X; Cai Y; Cai X; Zhang J; Liu J; Wang T; Wang J
Tumour Biol; 2014 Feb; 35(2):1139-42. PubMed ID: 24014088
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients.
Guo Y; Fan Y; Qiu J; Liu Y; Gao J; Guo F
PLoS One; 2012; 7(12):e51723. PubMed ID: 23300559
[TBL] [Abstract][Full Text] [Related]
27. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population.
Bharti V; Mohanti BK; Das SN
Hum Immunol; 2013 Mar; 74(3):348-52. PubMed ID: 23246583
[TBL] [Abstract][Full Text] [Related]
28. The functional cytotoxic T lymphocyte-associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer.
Yang M; Sun T; Zhou Y; Wang L; Liu L; Zhang X; Tang X; Zhou M; Kuang P; Tan W; Li H; Yuan Q; Yu D
Cancer; 2012 Oct; 118(19):4681-6. PubMed ID: 22359319
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
30. Association between the Cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis.
Zheng J; Yu X; Jiang L; Xiao M; Bai B; Lu J; Zhou Y
BMC Cancer; 2010 Oct; 10():522. PubMed ID: 20920330
[TBL] [Abstract][Full Text] [Related]
31. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
32. Minimizing the risk of posttransplant malignancy.
Campistol JM
Transplant Proc; 2008 Dec; 40(10 Suppl):S40-3. PubMed ID: 19100906
[TBL] [Abstract][Full Text] [Related]
33. CTLA-4 control over Foxp3+ regulatory T cell function.
Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
[TBL] [Abstract][Full Text] [Related]
34. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer.
Sun T; Zhou Y; Yang M; Hu Z; Tan W; Han X; Shi Y; Yao J; Guo Y; Yu D; Tian T; Zhou X; Shen H; Lin D
Cancer Res; 2008 Sep; 68(17):7025-34. PubMed ID: 18757416
[TBL] [Abstract][Full Text] [Related]
35. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.
Faul F; Erdfelder E; Lang AG; Buchner A
Behav Res Methods; 2007 May; 39(2):175-91. PubMed ID: 17695343
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
Gutierrez-Dalmau A; Campistol JM
Drugs; 2007; 67(8):1167-98. PubMed ID: 17521218
[TBL] [Abstract][Full Text] [Related]
37. Malignancies after renal transplantation during 33 years at a single center.
Végso G; Tóth M; Hídvégi M; Toronyi E; Langer RM; Dinya E; Tóth A; Perner F; Járay J
Pathol Oncol Res; 2007; 13(1):63-9. PubMed ID: 17387391
[TBL] [Abstract][Full Text] [Related]
38. Ctla-4 exon 1 (+49) and promoter (-318) gene polymorphisms in kidney transplantation.
Gorgi Y; Sfar I; Abdallah TB; Abderrahim E; Ayed SJ; Aouadi H; Bardi R; Ayed K
Transplant Proc; 2006 Sep; 38(7):2303-5. PubMed ID: 16980072
[TBL] [Abstract][Full Text] [Related]
39. Early diagnosis of cancer in renal transplant patients: a single center experience.
Yildirim Y; Ozyilkan O; Emiroglu R; Demirhan B; Karakayali H; Haberal M
Asian Pac J Cancer Prev; 2006; 7(2):336-9. PubMed ID: 16839235
[TBL] [Abstract][Full Text] [Related]
40. Post-transplant de novo malignancies in renal transplant recipients: the past and present.
Kauffman HM; Cherikh WS; McBride MA; Cheng Y; Hanto DW
Transpl Int; 2006 Aug; 19(8):607-20. PubMed ID: 16827677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
